scholarly article | Q13442814 |
P819 | ADS bibcode | 1985Sci...229..397S |
P356 | DOI | 10.1126/SCIENCE.3160114 |
P698 | PubMed publication ID | 3160114 |
P2093 | author name string | C E Smith | |
P Needleman | |||
K F Fok | |||
N R Siegel | |||
D Schwartz | |||
P T Manning | |||
D M Geller | |||
P433 | issue | 4711 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 397-400 | |
P577 | publication date | 1985-07-01 | |
P1433 | published in | Science | Q192864 |
P1476 | title | Ser-Leu-Arg-Arg-atriopeptin III: the major circulating form of atrial peptide | |
P478 | volume | 229 |
Q42086145 | A comparison of the vasodilator responses to atrial peptides in the pulmonary and renal arteries of the pig in vitro. |
Q70053162 | A novel biological effect of atrial natriuretic hormone: inhibition of mesangial cell mitogenesis |
Q41638179 | A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling |
Q35818693 | ANF in experimental congestive heart failure |
Q42136301 | Alteration of atrial natriuretic peptide levels by short term cadmium treatment |
Q69995698 | Atrial natriuretic factor |
Q40919655 | Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion |
Q44577084 | Atrial natriuretic factor in the impulse-conduction system of rat cardiac ventricles |
Q39177600 | Atrial natriuretic factor: a hormone secreted by the heart |
Q70013325 | Atrial natriuretic hormones--thirty years after the discovery of atrial volume receptors |
Q69349817 | Atrial natriuretic peptide (ANP) acts via specific binding sites on cGMP system of rat pancreatic islets without affecting insulin release |
Q44215518 | Atrial natriuretic peptide in dehydrated Long-Evans rats and Brattleboro rats |
Q41354216 | Atrial natriuretic peptide mRNA is regulated by glucocorticoids in vivo |
Q35601672 | Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells. Role of prostaglandin E2. |
Q39485181 | Atrial natriuretic peptide: blood levels in human disease and their measurement |
Q70045081 | Atrial natriuretic polypeptide: potential clinical applications |
Q46156248 | Autoradiographic localization of specific atrial natriuretic peptide binding sites on immunocytochemically identified cells in cultures from rat and guinea-pig hearts |
Q47424195 | Big ANF: large-molecular-weight ANF in rabbit plasma. II. Acid dissociation and HPLC of dissociated irANF |
Q44387932 | Biochemical studies of soluble atrial natriuretic peptide (ANP) receptors from rat olfactory bulb and vascular smooth muscle cells |
Q34567516 | Biologically active atrial peptides |
Q67898078 | Changes in the central ANF-system of renovascular hypertensive rats |
Q42858011 | Characterization of atrial-natriuretic-factor-receptor-coupled membrane guanylate cyclase from rat and mouse testes |
Q40379999 | Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats |
Q42857881 | Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor) |
Q22254421 | Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme |
Q37343367 | Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide |
Q42157076 | Degradation of atrial natriuretic factor in the rat. |
Q70029512 | Development, validation and application of an enzyme immunoassay (EIA) of atriopeptin |
Q34570295 | Developmental changes in the rat atriopeptin hormonal system |
Q38252579 | Discovery of atrial natriuretic factor in the brain: its characterization and cardiovascular implication |
Q70178037 | Divergence of ANF analogs in smooth muscle cell cGMP response and aorta vasorelaxation: evidence for receptor subtypes |
Q44679503 | Dual regulation of atrial natriuretic factor-dependent guanylate cyclase activity by ATP |
Q42464147 | Effects of arginine vasopressin and extracellular osmolarity on atrial natriuretic peptide release by superfused rat atria |
Q34559781 | Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats |
Q34599915 | Evolution of the membrane guanylate cyclase transduction system |
Q44242226 | Free and bound forms of atrial natriuretic peptide (ANP) in rat plasma: preferential increase of free ANP in spontaneously hypertensive rats (SHR) and stroke-prone SHR (SHRSP). |
Q35591380 | Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro |
Q46488275 | Genetically tailored atrial natriuretic factor-dependent guanylate cyclase. Immunological and functional identity with 180 kDa membrane guanylate cyclase and ATP signaling site |
Q34611830 | Identification of atrial natriuretic factor gene transcripts in the central nervous system of the rat. |
Q70012137 | Identification of the cardiac and circulating form of atriopeptin in rabbit |
Q41904825 | Identification, purification, and localization of tissue kallikrein in rat heart |
Q68427947 | Immuno-electron microscopy of atrial natriuretic factor secretory pathways in atria and ventricles of control and cardiomyopathic hamsters with heart failure |
Q69988164 | Immunoactive atrial natriuretic peptide in the rat eye: molecular forms in anterior uvea and retina |
Q70025123 | Immunocytochemical evidence for CDD/ANP-like peptides in strands of myoendocrine cells associated with the ventricular conduction system of the rat heart |
Q38975781 | Immunohistochemical localisation of natriuretic peptides in the brains and hearts of the spiny dogfish Squalus acanthias and the Atlantic hagfish Myxine glutinosa |
Q67709122 | In vitro stability of human atrial natriuretic peptide(h-ANP) |
Q33999594 | Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency |
Q35810897 | Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat |
Q70024139 | Isolation and structural analysis of the circulating human cardiodilatin (alpha ANP) |
Q69400181 | Isolation of bovine cardiodilatin by fast protein liquid chromatography and reversed-phase high-performance liquid chromatography |
Q33667452 | Manipulation of stretch-induced atriopeptin prohormone release and processing in the perfused rat heart |
Q37643593 | Membrane guanylate cyclase is a beautiful signal transduction machine: overview |
Q24337277 | Molecular biology of the natriuretic peptides and their receptors |
Q72714315 | Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy |
Q69060805 | Optimization of atrial natriuretic factor radioimmunoassay |
Q33571177 | Paradoxical relationship between atriopeptin plasma levels and diuresis-natriuresis induced by acute volume expansion |
Q69814147 | Phosphorylation of high- and low-molecular-mass atrial natriuretic peptide analogs by cyclic AMP-dependent protein kinase |
Q30461433 | Physiological concentrations of atrial natriuretic factor stimulate human erythroid progenitors in vitro |
Q67900811 | Presence of atrial natriuretic factor prohormone in enterochromaffin cells of the human large intestine |
Q41943759 | Rapid receptor-mediated catabolism of 125I-atrial natriuretic factor by vascular endothelial cells |
Q44772257 | Rat atrial secretory granules and pro-ANF processing enzyme |
Q52074651 | Regulation of atrial natriuretic peptide receptors in the rat brain. |
Q43589990 | Regulation of guanylate cyclase activity by atrial natriuretic factor and protein kinase C. |
Q69047351 | Responsiveness of the ANP providing system to volume load in conscious dogs |
Q70051925 | Secretion and biosynthesis of atrial natriuretic factor by cultured adrenal chromaffin cells |
Q67915637 | Significance of adrenoceptor-mediated atrial natriuretic factor release in normal humans |
Q28584023 | Site-directed mutational analysis of a membrane guanylate cyclase cDNA reveals the atrial natriuretic factor signaling site |
Q40379108 | Stretch-induced atriopeptin secretion in the isolated rat myocyte and its negative modulation by calcium |
Q34177016 | Synthesis and secretion of an atriopeptin-like protein in rat kidney cell culture |
Q35590430 | Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP. |
Q70046494 | Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure |
Q39479947 | The atrial natriuretic factor |
Q43094578 | The heart is an endocrine gland. |
Q35533947 | The natriuretic peptides and their receptors |
Q42855229 | The propeptide Asn1-Tyr126 is the storage form of rat atrial natriuretic factor |
Q67490709 | Three immunologically similar atrial natriuretic factor receptors |
Q73273646 | Type II transmembrane serine proteases |
Q69293893 | Ultrastructural aspects of atrium development: demonstration of endocardial discontinuities and immunolabeling of atrial natriuretic factor in the Syrian hamster |
Q43776068 | Ventricular and atrial myocytes of newborn rats synthesise and secrete atrial natriuretic peptide in culture: light- and electron-microscopical localisation and chromatographic examination of stored and secreted molecular forms. |
Q70062707 | Water immersion increases the concentration of the immunoreactive N-terminal fragment of proatrial natriuretic factor in human plasma |
Search more.